| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 26 |
| 1 | METHOTREXATE | 21 |
| 2 | RITUXIMAB | 17 |
| 3 | ALEMTUZUMAB | 15 |
| 4 | FINGOLIMOD | 15 |
| 5 | FINGOLIMOD HCL | 15 |
| 6 | FINGOLIMOD HYDROCHLORIDE | 15 |
| 7 | ACETAMINOPHEN | 14 |
| 8 | ERGOCALCIFEROL | 14 |
| 9 | METFORMIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HALOBETASOL PROPIONATE AND TAZAROTENE | 1 | 0.0051 |
| 1 | FINGOLIMOD HYDROCHLORIDE | 15 | 0.0029 |
| 2 | RESMETIROM | 3 | 0.0013 |
| 3 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 4 | PROBENECID | 1 | 0.0008 |
| 5 | TAZAROTENE | 1 | 0.0008 |
| 6 | NISOLDIPINE | 1 | 0.0008 |
| 7 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 8 | AZATHIOPRINE SODIUM | 2 | 0.0008 |
| 9 | ALEMTUZUMAB | 15 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 3 | 0.0013 |
| 1 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 16 | 0.0012 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 15 | 0.0008 |
| 3 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 4 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 6 | Androgen [EPC] | 4 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 8 | Rifamycin Antibacterial [EPC] | 4 | 0.0001 |
| 9 | Aminosalicylate [EPC] | 8 | 0.0001 |